CDNAF(CDNAF)
CDNAF
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $16.80B | $17.24B | $17.80B |
| Low | $16.68B | $16.85B | $17.54B |
| High | $17.17B | $18.00B | $18.39B |
| EBITDA Avg | $2.15B | $2.21B | $2.28B |
| Low | $2.14B | $2.16B | $2.25B |
| High | $2.20B | $2.31B | $2.36B |
| EBIT Avg | $1.39B | $1.42B | $1.47B |
| Low | $1.38B | $1.39B | $1.45B |
| High | $1.42B | $1.49B | $1.52B |
| Net Income Avg | $800M | $874M | $1.02B |
| Low | $785M | $857M | $1000M |
| High | $834M | $911M | $1.06B |
| EPS Avg | $14.69 | $16.05 | $18.72 |
| Low | $14.41 | $15.74 | $18.36 |
| High | $15.32 | $16.74 | $19.53 |
| Analysts (Rev / EPS) | 9 / 1 | 7 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $4.30B | $4.47B | $3.63B | $4.43B | $4.39B | $4.55B |
| Low | $4.25B | $4.42B | $3.60B | $4.38B | $4.35B | $4.50B |
| High | $4.35B | $4.53B | $3.68B | $4.48B | $4.45B | $4.60B |
| EBITDA Avg | $550M | $573M | $466M | $567M | $563M | $583M |
| Low | $545M | $567M | $461M | $561M | $557M | $577M |
| High | $557M | $580M | $471M | $574M | $570M | $590M |
| EBIT Avg | $355M | $369M | $300M | $365M | $363M | $375M |
| Low | $351M | $365M | $297M | $362M | $359M | $372M |
| High | $359M | $374M | $304M | $370M | $367M | $380M |
| Net Income Avg | $214M | $237M | $113M | $234M | $229M | $256M |
| Low | $211M | $233M | $112M | $230M | $226M | $253M |
| High | $217M | $240M | $115M | $237M | $233M | $261M |
| EPS Avg | $4.07 | $4.50 | $2.15 | $4.44 | $4.36 | $4.88 |
| Low | $4.01 | $4.44 | $2.13 | $4.38 | $4.30 | $4.81 |
| High | $4.14 | $4.57 | $2.19 | $4.52 | $4.43 | $4.96 |
| Analysts (Rev / EPS) | 5 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 |